Kidswell Bio Corporation (TYO:4584)

Kidswell Bio Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	3,233	3,294	2,995	1,187	1,461	2,032
Cash & Short-Term Investments	3,233	3,294	2,995	1,187	1,461	2,032
Cash Growth	13.84%	9.98%	152.32%	-18.75%	-28.10%	1.13%
Accounts Receivable	685	731	1,267	461	816	651
Other Receivables	-	141	50	-	-	-
Receivables	685	872	1,317	461	816	651
Inventory	414	363	1,475	988	450	254
Prepaid Expenses	-	6	16	-	-	-
Other Current Assets	1,562	1,305	897	689	619	385
Total Current Assets	5,894	5,840	6,700	3,325	3,346	3,322
Property, Plant & Equipment	17	17	1	1	3	1
Long-Term Investments	217	229	305	172	581	267
Other Intangible Assets	-	-	-	3	2	-
Other Long-Term Assets	2	2	2	2	1	2
Total Assets	6,130	6,088	7,008	3,503	3,933	3,592

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Accounts Payable	385	-	226	45	109	8
Short-Term Debt	-	-	-	-	-	25
Current Portion of Long-Term Debt	425	362	657	75	-	-
Current Income Taxes Payable	198	655	453	297	396	255
Other Current Liabilities	1,153	1,132	2,982	711	609	592
Total Current Liabilities	2,161	2,149	4,318	1,128	1,114	880
Long-Term Debt	2,050	2,187	1,180	625	1,100	1,200
Pension & Post-Retirement Benefits	43	57	41	31	19	19
Long-Term Deferred Tax Liabilities	38	39	56	-	89	-
Other Long-Term Liabilities	2	4	4	2	2	6
Total Liabilities	4,294	4,436	5,599	1,786	2,324	2,105

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Common Stock	192	191	2,317	1,421	1,032	611
Additional Paid-In Capital	2,568	2,566	11,623	10,726	10,337	9,917
Retained Earnings	-1,043	-1,241	-12,730	-10,613	-10,078	-9,077
Comprehensive Income & Other	119	136	199	183	318	36
Shareholders' Equity	1,836	1,652	1,409	1,717	1,609	1,487
Total Liabilities & Equity	6,130	6,088	7,008	3,503	3,933	3,592

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Total Debt	2,475	2,549	1,837	700	1,100	1,225
Net Cash (Debt)	758	745	1,158	487	361	807
Net Cash Growth	-41.30%	-35.66%	137.78%	34.90%	-55.27%	-59.84%
Net Cash Per Share	15.36	15.27	28.59	15.79	12.54	29.19
Filing Date Shares Outstanding	49.63	49.63	47.63	31.44	29.94	28.73
Total Common Shares Outstanding	49.63	49.62	43.88	31.44	29.62	27.65
Working Capital	3,733	3,691	2,382	2,197	2,232	2,442
Book Value Per Share	37.00	33.29	32.11	54.62	54.32	53.79
Tangible Book Value	1,836	1,652	1,409	1,714	1,607	1,487
Tangible Book Value Per Share	37.00	33.29	32.11	54.52	54.25	53.79

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 24, 2026

Data Sources Report a data error